HTLV-I associated myelopathy, a new clinical entity.

scientific article

HTLV-I associated myelopathy, a new clinical entity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(86)91298-5
P8608Fatcat IDrelease_xk4ilj4euvbxxmauvpsjfpetsq
P698PubMed publication ID2871307

P2093author name stringM Matsumoto
M Osame
S Izumo
K Usuku
A Igata
M Tara
N Ijichi
H Amitani
P2860cites workCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cellsQ34253011
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesisQ39021217
The basis of intra-blood-brain-barrier IgG synthesis.Q48554203
P433issue8488
P407language of work or nameEnglishQ1860
P921main subjectHuman T-lymphotropic virus 1Q1280388
P304page(s)1031-1032
P577publication date1986-05-01
P1433published inThe LancetQ939416
P1476titleHTLV-I associated myelopathy, a new clinical entity.
P478volume1

Reverse relations

cites work (P2860)
Q6338420240 years of the human T-cell leukemia virus: past, present, and future
Q341452075'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo
Q3957731471-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.
Q39418057A C77G point mutation in CD45 exon 4, which is associated with the development of multiple sclerosis and increased susceptibility to HIV-1 infection, is undetectable in Japanese population
Q36645522A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I.
Q43638796A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type I.
Q36666226A case of peripheral T-cell lymphoma, not otherwise specified in a HCV and HTLV-II-positive patient, diagnosed by abdominal fluid cytology
Q34339734A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy
Q36824252A cis element required for induction of the interleukin 2 enhancer by human T-cell leukemia virus type I binds a novel Tax-inducible nuclear protein
Q55239322A clinical survey of uveitis in HTLV-1 endemic region.
Q40874914A human B-lineage dendritic cell line, HBM-noda and its potential role in human T-cell leukemia/lymphoma virus type I infection
Q38992578A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases
Q40408082A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells
Q41652462A novel alternatively spliced viral mRNA transcribed in cells infected with human T cell leukemia virus type 1 is mainly responsible for expressing p21X protein
Q40582337A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design
Q34353702A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT.
Q39305535A possible association between HLA and HTLV-I-associated myelopathy (HAM) in Japanese
Q30485688A public HTLV-1 molecular epidemiology database for sequence management and data mining
Q39106672A rat model for human T lymphocyte virus type I-associated myeloneuropathy. down-regulation of bcl-2 expression and increase in sensitivity to TNF-alpha of the spinal oligodendrocytes
Q41397919A rat model of HTLV-I infection: development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis
Q36231807A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats
Q35533869A reduction of viral mRNA, proteins and induction of altered morphogenesis reveals the anti-HTLV-1 activity of the labdane-diterpene myriadenolide in vitro
Q55241678A seroepidemiological survey of antibodies to HTLV-I/HTLV-II in selected population groups in Paraguay
Q30425683A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system
Q41666767ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity
Q41246450ATL and HTLV-I: in vivo cell growth of ATL cells
Q36361378Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers
Q69903563Abnormal peripheral lymphocytes in tropical spastic paraparesis
Q39541639Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy
Q33490596Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder
Q39255855Absence of HTLV-II Co-infection in HTLV-I-associated Myelopathy Patients
Q36842571Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status
Q37071800Acetylation at lysine 346 controls the transforming activity of the HTLV-1 Tax oncoprotein in the Rat-1 fibroblast model
Q34283189Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template
Q33709523Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway
Q40399507Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells
Q36964053Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model
Q40497666Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors
Q94539493Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells
Q40407844Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression
Q33785951Activation of human T-cell leukemia virus type 1 tax gene expression in chronically infected T cells
Q39703814Activation of the PI3K-Akt pathway by human T cell leukemia virus type 1 (HTLV-1) oncoprotein Tax increases Bcl3 expression, which is associated with enhanced growth of HTLV-1-infected T cells
Q36315843Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1.
Q36652164Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.
Q35224934Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections
Q39611012Adult T cell leukaemia-lymphoma
Q55241690Adult T cell leukemia/lymphoma. Perspectives on the treatment.
Q60916408Adult T-Cell Leukemia/Lymphoma-Related Ocular Manifestations: Analysis of the First Large-Scale Nationwide Survey
Q72663098Adult T-cell leukaemia-lymphoma in Waldeyer's ring: a report of three cases
Q44635224Adult T-cell leukemia/lymphoma in Jujuy, north-west Argentina
Q55239437Adult T-cell leukemia/lymphoma in a 21-year-old man.
Q35782912Adult T-cell leukemia: future prophylaxis and immunotherapy
Q48737243Adult T-cell lymphoma involving the leptomeninges associated with a spinal cord schwannoma.
Q35674201Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry
Q39498023Age-dependent paraparesis in WKA rats: evaluation of MHC k-haplotype and HTLV-1 infection
Q39088537Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.
Q33823227Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies
Q39292518Amplification of HTLV-1-related sequences among patients with neurological disorders in highly endemic Nagasaki: lack of evidence for association of HTLV-1 with multiple sclerosis
Q39012004Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients
Q35608968An Evaluation of the Spontaneous Proliferation of Peripheral Blood Mononuclear Cells in HTLV-1-Infected Individuals Using Flow Cytometry
Q38865288An autopsy case of human T-lymphotropic virus type I-associated myelopathy
Q45435710Analysis of HLA class I and class II gene polymorphisms in Japanese patients with human T-cell lymphotropic virus type 1-associated uveitis
Q38714221Analysis of HTLV-1 proviral load (PVL) and antibody detected with various kinds of tests in Japanese blood donors to understand the relationship between PVL and antibody level and to gain insights toward better antibody testing
Q45025853Analysis of factors of relevance to rapid clinical progression in HTLV-I-associated myelopathy
Q30621111Analysis of human T-cell leukemia virus type 1 particles by using cryo-electron tomography
Q27621035Anchoring an extended HTLV-1 Rex peptide within an RNA major groove containing junctional base triples
Q38050763Animal models on HTLV-1 and related viruses: what did we learn?
Q36967203Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Q39594158Anti-Rex aptamers as mimics of the Rex-binding element.
Q45846668Antibodies against p40tax gene product of human T-lymphotropic virus type-I (HTLV-I) under various conditions of HTLV-I infection
Q44701780Antibodies against retroviral core proteins in relation to disease outcome in patients with mycosis fungoides
Q36831871Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people
Q55236780Antibody to HTLV-I in indigenous inhabitants of the Andes and Amazon regions in Colombia.
Q45856065Antibody to human T-lymphotropic virus in a patient with Guillain-Barré syndrome (case report)
Q39300934Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis
Q36056547Application of targeted enrichment to next-generation sequencing of retroviruses integrated into the host human genome
Q28727305Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy
Q40884401Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review
Q33562978Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier
Q64912641Association Between HTLV-1 Genotypes and Risk of HAM/TSP.
Q39504852Association between HLA Class I Alleles and Proviral Load in HTLV-I Associated Myelopathy/Tropical Spastic Paraperesis (HAM/TSP) Patients in Iranian Population
Q35123084Association between HLA-DQB1 alleles and HAM/TSP patients in Khorasan Province
Q39206746Association of CD40 ligand expression on HTLV-I-infected T cells and maturation of dendritic cells
Q39481239Association of Tuberculosis Status with Neurologic Disease and Immune Response in HTLV-1 Infection.
Q36548660Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells
Q39560951Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis
Q38301372Autoantigen Ku protein is involved in DNA binding proteins which recognize the U5 repressive element of human T-cell leukemia virus type I long terminal repeat
Q39255881Autonomous proliferation of HTLV-CD4+ T cell clones derived from human T cell leukemia virus type I (HTLV-I)-associated myelopathy patients
Q39153041Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations
Q92483504Balance Impairments in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection
Q35964522Barefoot Plantar Pressure Indicates Progressive Neurological Damage in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection
Q34198903Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry
Q26830903Blood-brain barrier and retroviral infections
Q80454564Bone marrow cells carrying the env-pX transgene play a role in the severity but not prolongation of arthritis in human T-cell leukaemia virus type-I transgenic rats: a possible role of articular tissues carrying the transgene in the prolongation of
Q45834139Bone marrow derived cells express human T-cell lymphotropic virus type I (HTLV-I)-related antigens in patients with multiple sclerosis
Q35000087Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo
Q37670477Brain Metabolism Changes in Patients Infected with HTLV-1
Q35537421Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers
Q42490427CCAAT/enhancer-binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation
Q34667760CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP
Q45362335Can thymic epithelial cells be infected by human T-lymphotropic virus type 1?
Q33388659Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread
Q37945242Cell surface markers in HTLV-1 pathogenesis
Q40831727Cell type-specific E2F activation and cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Q40714477Cell-free human T-cell leukemia virus type 1 binds to, and efficiently enters mouse cells
Q36049779Cellular Factors Involved in HTLV-1 Entry and Pathogenicit
Q39173052Cellular and humoral immune responses associated with HTLV-I associated myelopathy/tropical spastic paraparesis
Q39013567Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Q90400891Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Q48960065Chapter 47: history of clinical neurology in Japan.
Q35833900Characteristics of Adult T-Cell Leukemia/Lymphoma Patients with Long Survival: Prognostic Significance of Skin Lesions and Possible Beneficial Role of Valproic Acid
Q39092412Characterization of T cells transmigrating through human endothelial cells in patients with HTLV-I-associated myelopathy.
Q44798682Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein
Q35837041Characterization of an infectious molecular clone of human T-cell leukemia virus type I.
Q33590318Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection.
Q39097191Characterization of two human lymphoid cell lines producing human T-lymphotropic virus type I (HTLV-I) isolated from patients with HTLV-I-associated myelopathy or encephalopathy
Q55027437Chemiluminescence immunoassay to detect anti-HTLV-I antibodies.
Q45743242Chemokine synthesis and cellular inflammatory changes in lungs of mice bearing p40tax of human T-lymphotropic virus type 1.
Q39270237Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans
Q38290883Chimeric proteins composed of Jun and CREB define domains required for interaction with the human T-cell leukemia virus type 1 Tax protein.
Q81773135Chronic graft-versus-host disease-like autoimmune disorders spontaneously occurred in rats with neonatal thymus atrophy
Q33588882Chronic polyradiculoneuropathy associated with human T-cell lymphotropic virus type I infection
Q68338832Chronic progressive myelopathy: its relation to the spinal progressive form of multiple sclerosis
Q37107022Chronic transmural bronchiolitis: a non-specific lesion of small airways
Q28484214Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis
Q39098415Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease
Q36422133Clinical Trials and Treatment of ATL.
Q45776151Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis.
Q43777263Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis
Q39457794Clinical and physiological significance of abnormally prolonged central motor conduction time in HAM/TSP.
Q38905700Clinical evolution of tropical spastic paraparesis: The Tumaco experience
Q39459002Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran
Q40983529Clinical implication of the integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma
Q41646096Clinical indications of multiple integrations of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma
Q36994979Clinical manifestations associated with HTLV type I infection: a cross-sectional study
Q21131133Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis
Q55240045Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.
Q92554749Clinical trial of a humanized anti-IL-2/IL-15 receptor β chain in HAM/TSP
Q45434328Clinicopathological and virological analyses of familial human T-lymphotropic virus type I--associated polyneuropathy
Q34156338Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients
Q44532039Cloning and expression of the transmembranic glycoprotein from human T cell lymphotropic virus in a prokaryotic system
Q24309545Cloning of novel isoforms of the human Gli2 oncogene and their activities to enhance tax-dependent transcription of the human T-cell leukemia virus type 1 genome
Q34466396Co-dependence of HTLV-1 p12 and p8 functions in virus persistence
Q39319460Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.
Q35101485Coactivator-associated arginine methyltransferase 1 enhances transcriptional activity of the human T-cell lymphotropic virus type 1 long terminal repeat through direct interaction with Tax.
Q41707235Coexistence of Fusion Receptors for Human T-Cell Leukemia Virus Type-I (HTLV-I) and Human Immunodeficiency Virus Type-1 (HIV-1) on MOLT-4 Cells
Q55239264Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients.
Q37700567Combined cytolytic effects of a vaccinia virus encoding a single chain trimer of MHC-I with a Tax-epitope and Tax-specific CTLs on HTLV-I-infected cells in a rat model.
Q55239039Complete Sequences of the Human T-Cell Leukemia Virus Type 1 Proviral Genomes from Newly Established Adult T-Cell Leukemia Cell Lines in Oita Prefecture, Japan.
Q36560393Complex formation between CREB and Tax enhances the binding affinity of CREB for the human T-cell leukemia virus type 1 21-base-pair repeats
Q55026249Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation.
Q44620586Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II
Q89509154Conservation of a Neutralization Epitope of Human T-cell Leukemia Virus Type 1 (HTLV-1) among Currently Endemic Clinical Isolates in Okinawa, Japan
Q35763367Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells
Q39580554Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene
Q39269105Constitutive expression of the cyclooxygenase-2 gene in T-cell lines infected with human T cell leukemia virus type I.
Q26852683Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?
Q35780796Correlation between LTR point mutations and proviral load levels among human T cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers
Q34342472Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model
Q35862019Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax.
Q97067407Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
Q39167266Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease
Q27617901Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins
Q38634316Current concepts about multiple sclerosis
Q50520637Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.
Q37198681Current topics in prevention of human T-cell leukemia virus type i infection: NF-kappa B inhibitors and APOBEC3.
Q39452117Cutaneous and neurologic disease associated with HTLV-I infection
Q41170711Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I.
Q36251464Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Q33910622DC-SIGN (CD209) gene promoter polymorphisms in a Brazilian population and their association with human T-cell lymphotropic virus type 1 infection
Q40287235DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells
Q40541784DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations
Q38983203DNA sequence analysis of the gene encoding the HTLV-I P21E transmembrane protein reveals inter- and intraisolate genetic heterogeneity
Q39292402De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice
Q44718738Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers
Q42050696Degeneration of oxidative muscle fibers in HTLV-1 tax transgenic mice
Q34157297Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice
Q37672616Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).
Q36103218Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.
Q35765050Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma
Q33256730Detection of HTLV-I and -II in Scottish blood donor samples and archive donations
Q36363731Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis
Q45758441Detection of human T lymphotropic virus type I proviral DNA in patients with diffuse panbronchiolitis
Q38928344Detection of human T-cell lymphotropic virus type 1 in plasma samples.
Q35259821Detection of human retroviruses by PCR
Q33850951Detection of provirus in an HTLV-II producer CD8+ T cell line by polymerase chain reaction combined with digoxigenin-ELISA method
Q41397145Detection of the cellular membrane proteins on human T cell leukemia virus type I.
Q39528053Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections
Q39150767Development of [Ile⁴⁰]HTLV-I protease inhibition assay using novel fluorogenic and chromogenic substrate
Q41630418Development of a supersensitive polymerase chain reaction method for human T lymphotropic virus type II (HTLV-II) and detection of HTLV-II proviral DNA from blood donors in Japan
Q37171376Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1).
Q69241776Diagnosis of multiple sclerosis
Q39092457Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals
Q40451275Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP.
Q39139884Differential diagnosis of HTLV-I-associated myelopathy and multiple sclerosis in Iranian patients
Q37691270Differential diagnosis of white matter diseases in the tropics: An overview
Q46613891Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma
Q37191904Dimerization and a novel Tax speckled structure localization signal are required for Tax nuclear localization
Q36498251Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients
Q39010923Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP).
Q39010929Disability profile of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM).
Q34450086Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis
Q39171333Discrepancy, coincidence or evidence in chronic idiopathic spastic paraparesis throughout the world. A meta-analysis on 2811 patients
Q36947017Distinct Morphology of Human T-Cell Leukemia Virus Type 1-Like Particles.
Q58765362Distinct Pathway of Human T-Cell Leukemia Virus Type 1 Gag Punctum Biogenesis Provides New Insights into Enveloped Virus Assembly
Q37657776Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis
Q58608708Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP
Q33605874Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 Tax protein
Q35826764Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion
Q39139873Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.
Q39141890Do human T-lymphotrophic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis?
Q40044710Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.
Q40066482Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance
Q37827194Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity
Q37337951Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways.
Q38867016Dysautonomia in human T-cell lymphotrophic virus type I-associated myelopathy/tropical spastic paraparesis
Q36713538Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease
Q92128584EOS, an Ikaros family zinc finger transcription factor, interacts with the HTLV-1 oncoprotein Tax and is downregulated in peripheral blood mononuclear cells of HTLV-1-infected individuals, irrespective of clinical statuses
Q35989638Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.
Q35663886Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals
Q33825371Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy
Q34113074Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro
Q38768079Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study
Q36689405Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1
Q39311297Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
Q40784053Efficacy of 3'-azido 3'deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells.
Q55239076Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus-1 associated myelopathy.
Q34941384Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial
Q39412421Efficient transfer of HTLV-1 tax gene in various primary and immortalized cells using a flap lentiviral vector
Q39688951Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.
Q39014388Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy
Q39558557Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases
Q35857603Enhanced replication of human T-cell leukemia virus type 1 in T cells from transgenic rats expressing human CRM1 that is regulated in a natural manner
Q55240469Enhancement of nucleocytoplasmic export of HTLV-1 Rex mRNA through cis and trans interactions of the mRNA with the complex of Rex protein and Rex-responsive element.
Q35826330Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures
Q55242078Epidemiologic assessment of screening tests for antibody to human T lymphotropic virus type I (HTLV-I).
Q28534288Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central China
Q40041843Epidemiological and clinical features of adult T-cell leukemia-lymphoma (ATL) in Japan, 2010-2011: a nationwide survey
Q30371156Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs.
Q38934609Erectile dysfunction and HTLV-I infection: a silent problem
Q91967430Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice
Q33816840Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax.
Q40991139Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1.
Q54736313Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting.
Q36794828Evaluation of commercial HTLV-1 test kits by a standard HTLV-1 serum panel.
Q52480067Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II
Q45846671Evaluation of the human T-cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test
Q55240554Evidence of HTLV-I in thyroid tissue in an HTLV-I carrier with Hashimoto's thyroiditis.
Q92478942Evidence of New Endemic Clusters of Human T-Cell Leukemia Virus (HTLV) Infection in Bahia, Brazil
Q50930958Evidence of a higher prevalence of HPV infection in HTLV-1-infected women: a cross-sectional study.
Q33933778Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea
Q35891748Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide
Q24803711Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
Q33854237Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors
Q34150778Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein
Q34587031Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.
Q34756170Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response
Q38954009Experimental HTLV-I infection and associated myelopathy
Q41500975Exposure of p19 matrix protein of human T-cell leukemia virus type I (HTLV-I) on the surface of MOLT-4#8 cells after virus adsorption
Q39095798Expression and significance of Pim-3 kinase in adult T-cell leukemia.
Q33707390Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion
Q39067179Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals
Q54205015Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1.
Q55240032Expression, purification and biological properties of the carboxyl half part of the HTLV-I surface envelope glycoprotein.
Q44385186Extraordinary High Rate of HTLV Type II Seropositivity in Intravenous Drug Abusers in South Vietnam
Q55239347Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area.
Q39136776Failure in activation of the canonical NF-κB pathway by human T-cell leukemia virus type 1 Tax in non-hematopoietic cell lines
Q33573817Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis
Q34779059Familial transmission of human T-cell lymphotrophic virus: silent dissemination of an emerging but neglected infection
Q55239042Fine-scale geographic clustering pattern of human T-cell leukemia virus type 1 infection among blood donors in Kyushu-Okinawa, Japan.
Q42160153Forefront studies on HTLV-1 oncogenesis
Q30991310Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein
Q39014319Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Q36694078Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis
Q33944410Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B.
Q40301664Functional analysis of human T lymphotropic virus type 2 Tax proteins
Q40106375Functional analysis of human T-cell leukemia virus type I rex-response element: direct RNA binding of Rex protein correlates with in vivo activity
Q40784058Functional changes in astrocytes by human T-lymphotropic virus type-1 T-lymphocytes
Q33495989Functional interaction of HTLV-1 tax protein with the POZ domain of the transcriptional repressor BCL6.
Q35984815Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo
Q39605657GLI-2 modulates retroviral gene expression
Q35635241GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1.
Q35105616Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission
Q41402428Gene expression of neurotropic retrovirus in the CNS.
Q33713794Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients
Q39381446Genetic characterization and phylogeny of human T-cell lymphotropic virus type I from Chile
Q33655605Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.
Q33834966Genetic evidence of a role for ATM in functional interaction between human T-cell leukemia virus type 1 Tax and p53.
Q39307467Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease
Q34529971Genome editing and the next generation of antiviral therapy.
Q41192007Geographic and molecular epidemiology of primate T lymphotropic retroviruses: HTLV-I, HTLV-II, STLV-I, STLV-PP, and PTLV-L.
Q45852141Geographical distribution of subjects seropositive for human T-cell leukemia virus type 1 in Papua New Guinea
Q36254899Global epidemiology of HTLV-I infection and associated diseases
Q39124772Graves' disease in HTLV-I carriers
Q36966593HAM/TSP attributable to blood transfusion
Q36452983HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
Q36379492HLA class II disease associations in southern Africa
Q55239505HPRT mutations, TCR gene rearrangements, and HTLV-1 integration sites define in vivo T-cell clonal lineages.
Q33734795HTLV 1 associated myelopathy and adult T cell leukaemia-lymphoma in the same patient: report of a case
Q64085048HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients
Q89965417HTLV-1 Infection and Rheumatic Diseases
Q33779850HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro
Q21134702HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter
Q37021560HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase
Q37152235HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking.
Q39172189HTLV-1 and myelopathy in Salvador (northeastern Brazil): a case control study
Q39268748HTLV-1 and polymyositis in Jamaica
Q39292062HTLV-1 associated myelopathy in an HTLV-1 and HBV double carrier family: report of a case and the mode of vertical transmission of both viruses
Q35669209HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines
Q34567317HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo
Q34998237HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression
Q92017170HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
Q92212791HTLV-1 infection of myeloid cells: from transmission to immune alterations
Q34043666HTLV-1 infections
Q39403898HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics
Q36269748HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil
Q36112549HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals
Q55240878HTLV-1 oncoprotein Tax deregulates transcription of cellular genes through multiple mechanisms.
Q54246956HTLV-1 proviral load in cerebrospinal fluid may not be a good marker to differentiate asymptomatic carriers with high proviral load in blood from HAM/TSP patients.
Q39479028HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking
Q31151159HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection
Q39614932HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors
Q24607794HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications
Q36111401HTLV-1 uveitis
Q57825486HTLV-1, ATLL, severe hypercalcaemia and HIV-1 co-infection: an overview
Q47562043HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment
Q36279205HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene
Q59354958HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-Lymphoma
Q38060839HTLV-1-associated infective dermatitis: updates on the pathogenesis
Q67665443HTLV-1-associated myelopathy (HAM) with OKT4 epitope deficiency
Q45096240HTLV-1-associated myelopathy/tropical spastic paraparesis
Q39153396HTLV-1-associated myelopathy/tropical spastic paraparesis-like rats by intravenous injection of HTLV-1-producing rabbit or human T-cell line into adult WKA rats
Q36352523HTLV-1-infected T cells contain a single integrated provirus in natural infection
Q59355916HTLV-1/2 prevalence in two Amazonian communities
Q44902398HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up
Q36298491HTLV-2 Tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy
Q38964582HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil
Q34599506HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated
Q33567646HTLV-I associated arthritis: characteristics of an HTLV-I virus infected T cell line from synovial fluid.
Q38934593HTLV-I associated myelopathy in Brazil: a preliminary report
Q39370492HTLV-I associated myelopathy in patients from Brazil and Iran: neurological manifestations and cerebrospinal fluid findings
Q39242059HTLV-I associated myelopathy in salvador (northeastern Brazil)
Q39317795HTLV-I associated myelopathy: a case of viral-induced auto-immunity
Q39020706HTLV-I associated sicca syndrome in Guadeloupe: lack of relation with a peculiar encoding sequence of surface envelope glycoprotein
Q37316339HTLV-I associated uveitis in central Japan
Q43699477HTLV-I carrier with unusual brain MR imaging findings
Q54699187HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy.
Q39611577HTLV-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia
Q36958734HTLV-I infection and neurological disease in Rio de Janeiro
Q43312366HTLV-I infection in French West Indies: a case-control study
Q33648572HTLV-I infection in human disease
Q45833275HTLV-I myelitis: isolation of virus, genomic analysis, and infection in neural cell cultures
Q69367951HTLV-I positive spastic paraparesis in a temperate zone
Q39149923HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals
Q55081753HTLV-I uveitis: a distinct clinical entity caused by HTLV-I
Q55242900HTLV-I, brain abnormalities on magnetic resonance imaging, and relation with multiple sclerosis.
Q55243841HTLV-I, visna, and tropical spastic paraparesis.
Q55242670HTLV-I-associated meningitis.
Q34063870HTLV-I-associated myelopathy
Q39014393HTLV-I-associated myelopathy associated with multi-organ inflammatory disease: a case report
Q55240344HTLV-I-infected T cells activate autologous CD4+ T cells susceptible to HTLV-I infection in a costimulatory molecule-dependent fashion.
Q43459274HTLV-II among Italian intravenous drug users and hemophiliacs.
Q42574751HTLV-II infection in the Western United States
Q46580842HTLV-Is in Argentina are phylogenetically similar to those of other South American countries, but different from HTLV-Is in Africa
Q24312994HUB1, a novel Krüppel type zinc finger protein, represses the human T cell leukemia virus type I long terminal repeat-mediated expression
Q35757329Helminthic infection and the risk of neurologic disease progression in HTLV-1
Q44701841Hematopoietic progenitor cells as possible origins of epithelial thymoma in a human T lymphocyte virus type I pX gene transgenic rat model
Q39715394Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil
Q55239907High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.
Q30973354High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease
Q45767249High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies
Q37014310High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response
Q36890075High frequency of virus-specific CD8+ T cells in the central nervous system of macaques chronically infected with simian immunodeficiency virus SIVmac251.
Q40741437High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders
Q36637030High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells.
Q55240500High occurrence of primary malignant neoplasms in patients with adult T-cell leukemia/lymphoma, their siblings, and their mothers.
Q33578804High prevalence of arthropathy in HTLV-I carriers on a Japanese island
Q35682787High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease
Q37288904High prevalence of skin disorders among HTLV-1 infected individuals independent of clinical status
Q33183253High variability of HTLV-I in a remote population of Gabon as compared to that of a similar population of French Guiana
Q21131117Highlights on distinctive structural and functional properties of HTLV Tax proteins
Q33318640Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells
Q42452746Histopathological and immunohistochemical assessment of acquired ichthyosis in patients with human T-cell lymphotropic virus type I-associated myelopathy.
Q38997386Home-based exercise program in TSP/HAM individuals: a feasibility and effectiveness study
Q35516989Hospital admissions for human T-cell lymphotropic virus type-1 (HTLV-1) associated diseases in Dominica
Q39139856Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101.
Q36736791Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans
Q35261245Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Q39081259Human T cell leukaemia virus type 2 tax protein mediates CC-chemokine expression in peripheral blood mononuclear cells via the nuclear factor kappa B canonical pathway
Q33992848Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells
Q41881538Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO.
Q39047641Human T cell leukemia virus type I Tax activates CD40 gene expression via the NF-kappa B pathway
Q45735789Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells
Q39097151Human T cell leukemia virus type I infection and chronic myelopathy
Q35111367Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration
Q39093706Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha/CCL20 gene transcription via the NF-kappa B pathway
Q33536189Human T cell leukemia virus type-I and rheumatoid arthritis
Q39031445Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Q37182373Human T cell lymphotropic virus type 1 infection and early neurologic development: a pilot study of 48 children
Q33588672Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa
Q42942655Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma
Q34105919Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers
Q37123327Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism
Q37305002Human T lymphotropic virus type 1 uveitis
Q37305220Human T lymphotropic virus type 1 uveitis after Graves' disease
Q45748119Human T lymphotropic virus type I (HTLV-I) infection in neurological patients in Salvador, Bahia, Brazil
Q39153673Human T lymphotropic virus type I associated myelopathy with pulmonary and cutaneous lesions
Q39120168Human T lymphotropic virus-1 infection
Q39531858Human T-Cell Lymphotrophic Virus in California's Injection Drug Users
Q36552267Human T-Cell Lymphotropic Virus Type I and II in Transfusion Medicine
Q35112026Human T-Cell Lymphotropic Virus Type I and Neurological Diseases
Q37160107Human T-Lymphotropic Virus (HTLV) Type I in vivo Integration in Oral Keratinocytes
Q59353305Human T-Lymphotropic Virus-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Associated With Sexual Dysfunction in Infected Women of Reproductive Age
Q38256603Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
Q40475835Human T-cell leukaemia virus.
Q35057537Human T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling
Q36688419Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type 1 Rev-responsive element
Q34233092Human T-cell leukemia virus open reading frame II encodes a posttranscriptional repressor that is recruited at the level of transcription.
Q35024063Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells
Q35635372Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription.
Q24671809Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, etc.
Q33777633Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases
Q38288604Human T-cell leukemia virus type 1 Tax modulates interferon-alpha signal transduction through competitive usage of the coactivator CBP/p300.
Q40581800Human T-cell leukemia virus type 1 Tax oncoprotein induces and interacts with a multi-PDZ domain protein, MAGI-3.
Q36974745Human T-cell leukemia virus type 1 Tax relieves repression of proliferating cell nuclear antigen gene expression
Q37644070Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis
Q40967217Human T-cell leukemia virus type 1 can infect a wide variety of cells in mice
Q39578739Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes
Q42619328Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity
Q24805664Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
Q41431590Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene
Q41489682Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency
Q36828828Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation
Q40063976Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation
Q39028120Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor
Q39937243Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules
Q39269100Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor-kappaB and c-AMP responsive element binding protein pathways
Q36812848Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells
Q36683008Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy
Q45731173Human T-cell lymphotrophic virus infection in organ donors: a need to reassess policy?
Q34012655Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage
Q41097684Human T-cell lymphotropic virus type 1 can infect primary rat retinal glial cells and induce gene expression of inflammatory cytokines
Q33999613Human T-cell lymphotropic virus type 1 tax among American blood donors
Q24525274Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha
Q39263618Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis
Q59351127Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand
Q37781457Human T-cell lymphotropic virus type I sequences detected by nested polymerase chain reactions are not associated with multiple sclerosis
Q36990286Human T-cell lymphotropic virus, type 1 (HTLV-1)-associated myelopathy: MR findings
Q33876219Human T-cell lymphotropic virus-I in Latin America
Q42998030Human T-lymphotrophic virus type I nucleocapsid protein NCp15: structural study and stability of the N-terminal zinc-finger
Q34610888Human T-lymphotropic virus 1: recent knowledge about an ancient infection
Q35276727Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease
Q35611766Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control
Q38104766Human T-lymphotropic virus type 1 non-structural proteins: Requirements for latent infection
Q33827304Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters
Q35847599Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction
Q36617341Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.
Q33557951Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii
Q39124606Human T-lymphotropic virus type I (HTLV-I)-specific CD8+ cells accumulate in the lungs of patients infected with HTLV-I with pulmonary involvement
Q40848250Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent.
Q39611006Human T-lymphotropic virus type I in Japan
Q33661263Human T-lymphotropic virus type I infection
Q33929845Human T-lymphotropic virus type I provirus and T-cell prolymphocytic leukemia
Q45753518Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors
Q27301309Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography
Q41627464Human T‐Cell Leukemia Virus‐1‐positive Cell Line Established from a Patient with Small Cell Lung Cancer
Q36575342Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods
Q40426651Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation
Q47391092Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax.
Q55359316Human retrovirus promotes the plasticity of regulatory T cells into T helper type 1-like cells through the T-bet transcriptional activation in neuroinflammatory disease.
Q40429916Human retroviruses in the second decade: A personal perspective
Q38247882Human retroviruses: a common virology
Q36646919Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
Q68235341Hypercalcemia and production of parathyroid hormon.e-like protein in adult T-cell leukemia-lymphoma
Q40429356I-mfa domain proteins specifically interact with HTLV-1 Tax and repress its transactivating functions.
Q55239413IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.
Q40041190IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.
Q31811740IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II.
Q38297147IL-2 withdrawal induces HTLV-1 expression through p38 activation in ATL cell lines
Q35856454Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.
Q45368177Identification of CD44 as a downstream target of noncanonical NF-κB pathway activated by human T-cell leukemia virus type 1-encoded Tax protein
Q55154170Identification of HTLV-I sequence in cord blood mononuclear cells of neonates born to HTLV-I antigen/antibody-positive mothers by polymerase chain reaction.
Q38339893Identification of a functional serum response element in the HTLV-I LTR.
Q38342800Identification of an osteoclast transcription factor that binds to the human T cell leukemia virus type I-long terminal repeat enhancer element
Q41549343Identification of novel singly spliced pX mRNA transcripts common to all human T-cell leukemia virus type 1-related retroviruses
Q41402570Identification of phosphocholine-containing glycoglycerolipids purified from Mycoplasma fermentans-infected human helper T-cell culture as components of M. fermentans
Q37541342Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides
Q55242553Identity of HTLV-I-associated tropical spastic paraparesis and HTLV-I-associated myelopathy.
Q45881272Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies
Q35873798Imbalanced expression of glutamate-glutamine cycle enzymes induced by human T-cell lymphotropic virus type 1 Tax protein in cultivated astrocytes
Q39594099Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone
Q41404176Immune recognition of genetically diverse simian T-cell lymphotropic virus type I isolates
Q33651831Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Q36944303Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia
Q44091851Immunologic response and proviral load in human T-lymphotropic virus type 1 infected individuals with erectile dysfunction
Q39487416Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity
Q39139566Immunological studies of HTLV-I associated myelopathy
Q34157538Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis
Q36422111Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives
Q34203309Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production
Q55039421Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases.
Q38885843Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease
Q35125077Impact of donor infections on outcome of orthotopic liver transplantation
Q92787350Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL
Q46606105Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2.
Q39481246Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid
Q36944299Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia
Q37247983Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay
Q38900247In situ hybridization detection of HTLV-I RNA in peripheral blood mononuclear cells of TSP/HAM patients and their spouses
Q35871154In vitro CD4+ lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotrophic virus type 1
Q55240633In vitro effects of immunosuppressive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis.
Q41403895In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors
Q44771773In vitro transmission and antigenicity of a retrovirus isolated from a multiple sclerosis patient
Q36231574In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II).
Q37122656In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Q39381418In vivo fluctuation of Tax, Foxp3, CTLA-4, and GITR mRNA expression in CD4(+)CD25(+) T cells of patients with human T-lymphotropic virus type 1-associated myelopathy
Q39612164In vivo genomic footprinting of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat enhancer sequences in HTLV-1-infected human T-cell lines with different levels of Tax I activity
Q36701505In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies
Q39601697In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes
Q39448054Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis
Q39279168Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers
Q39289897Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.
Q36859157Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
Q36399192Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies i
Q39422572Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients
Q37311248Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study
Q24805302Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease
Q37347687Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe?
Q64097659Induction of APOBEC3B cytidine deaminase in HTLV-1-infected humanized mice
Q35909704Induction of Cell Death in Growing Human T-Cells and Cell Survival in Resting Cells in Response to the Human T-Cell Leukemia Virus Type 1 Tax.
Q33815891Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells.
Q36635959Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization
Q39433754Induction of cytokines in glial cells by trans activator of human T-cell lymphotropic virus type I
Q45747449Induction of lymphocytic inflammatory changes in lung interstitium by human T lymphotropic virus type I.
Q33905638Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells
Q40671290Infection of the central nervous system by human retroviruses
Q37536047Infectivity of chimeric human T-cell leukemia virus type I molecular clones assessed by naked DNA inoculation
Q38864827Infectivity of human T-lymphotropic virus type I to human nervous tissue cells in vitro
Q39097159Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection
Q39421770Inflammatory lesions of peripheral nerve in a patient with human T-lymphotropic virus type I--associated myelopathy
Q38262169Inflammatory manifestations of HTLV-1 and their therapeutic options
Q45722152Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity
Q44084238Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis
Q42241090Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection
Q59356083Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine
Q39596759Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.
Q39207637Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.
Q35491663Inhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells
Q35036496Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
Q39576689Inhibition of human T-lymphotropic virus type I gene expression by the Streptomyces-derived substance EM2487.
Q36424037Inhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells
Q34069424Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein
Q36522664Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro: evaluation of saliva as an alternative source of transmission
Q33843431Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis
Q39550065Interaction of Gli2 with CREB protein on DNA elements in the long terminal repeat of human T-cell leukemia virus type 1 is responsible for transcriptional activation by tax protein
Q45764767Interaction of human T-cell lymphotropic virus type I Tax, Ets1, and Sp1 in transactivation of the PTHrP P2 promoter
Q36561858Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA
Q33806783Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system
Q39001989Interferon-alpha significantly reduces cerebrospinal fluid CD4 cell subsets in HAM/TSP.
Q39138332Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells
Q47763655Interleukin-10 gene expression and adult T-cell leukemia
Q34192816Interleukin-13 overexpression by tax transactivation: a potential autocrine stimulus in human T-cell leukemia virus-infected lymphocytes
Q39403386Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection
Q39411009Interleukin-6 production in "normal" and HTLV-1 tax-expressing brain-specific endothelial cells
Q36981737Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy
Q47601290Interpretation of low reactivity in the Abbott Architect rHTLV I/II assay
Q58691752Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testing
Q35833293Intrauterine transmission of human T-cell leukemia virus type I in rats
Q40736260Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis
Q41014732Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation
Q39815291Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1.
Q45751487Involvement of autoimmunity against type II collagen in the development of arthritis in mice transgenic for the human T cell leukemia virus type I tax gene
Q35092867Is Sjögren's syndrome a retroviral disease?
Q30913837Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) syndrome a neglected disease?
Q35047215Isokinetic trunk and knee muscle strengths and gait performance in walking patients with T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP).
Q28776767Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys
Q39098426Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis
Q24648442Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I
Q38878558Juvenile human T lymphotropic virus type 1-associated myelopathy
Q35229171Lack of association of Borna disease virus and human T-cell leukemia virus type 1 infections with psychiatric disorders among Japanese patients
Q57830454Letters to the editors
Q39579844Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens
Q39173036Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia
Q36735681Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo
Q39220045Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?
Q24658333Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection
Q33932108Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations
Q33650199Low prevalence of flower cells in U.S.A. blood donors infected with human T-lymphotrophic virus types I and II.
Q45399118Low prevalence of human T cell lymphotropic virus type 1 infection in patients with gastric cancer.
Q39512828Low-back pain in HTLV-I-associated myelopathy/tropical spastic paraparesis: nociceptive or neuropathic?
Q39297216Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.
Q33622071Lupus nephritis class I accompanied by tubulointerstitial nephritis with marked T-lymphocyte infiltration in an HTLV-1 positive patient
Q33590603MRI-pathological correlate of brain lesions in a necropsy case of HTLV-I associated myelopathy
Q39563472Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).
Q42283356Mannose binding lectin and mannose binding lectin-associated serine protease-2 genes polymorphisms in human T-lymphotropic virus infection.
Q36702147Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins
Q33637013Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis
Q54997268Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals
Q26863681Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus
Q38914690Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
Q37183161Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells
Q57296147Metabolic abnormalities in adult T-cell leukemia/lymphoma and induction of specific leukemic cell death using photodynamic therapy
Q40267356Methods for Identifying and Examining HTLV-1 HBZ Post-translational Modifications
Q37067623MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes
Q35812057Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease
Q36099271Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein
Q39611634Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy
Q26752562Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission
Q41724491Molecular and Cellular Mechanism of Leukemogenesis of ATL: Emergent Evidence of a Significant Role for HBZ in HTLV-1-Induced Pathogenesis
Q42836979Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication
Q38867574Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients
Q37692056Molecular approach to human leukemia: isolation and characterization of the first human retrovirus HTLV-1 and its impact on tumorigenesis in adult T-cell leukemia
Q30698124Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).
Q37648645Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia
Q36690145Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals
Q35136041Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology
Q36958543Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax
Q33575495Molecular cloning of human T-cell lymphotrophic virus type I-like proviral genome from the peripheral lymphocyte DNA of a patient with chronic neurologic disorders
Q39443979Molecular detection and isolation of human T-cell lymphotropic virus type I (HTLV-I) from patients with HAM/TSP in São Paulo, Brazil.
Q35261463Molecular determinants of human T-lymphotropic virus type 1 transmission and spread
Q92016839Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes
Q40804672Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Q34450092Molecular mechanisms of cellular transformation by HTLV-1 Tax.
Q41035613Molecular mechanisms of promoter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human T cell leukemia virus type I.
Q45764235Molecular phylogeny of human T-cell leukemia virus type I and II of Amerindians in Colombia and Chile
Q39014284Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease
Q50604367Mortality among inhabitants of an HTLV-I endemic area in Japan.
Q36419884Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau
Q55243202Mother-to-child transmission in HTLV-I associated myelopathy.
Q39496391Motor and somatosensory evoked potential findings in HTLV-I associated myelopathy
Q35138158Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma
Q39581878Multimer formation is not essential for nuclear export of human T-cell leukemia virus type 1 Rex trans-activator protein
Q33631253Multimodality evoked potentials in HTLV-I associated myelopathy
Q33933008Multiple isolates and characteristics of human T-cell leukemia virus type II
Q57224696Multiple sclerosis (not tropical spastic paraparesis) on Key West, Florida
Q55239594Multiplex PCR using real time DNA amplification for the rapid detection and quantitation of HTLV I or II.
Q38546539Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention
Q38327790Multistep regulation of enhancer activity of the 21-base-pair element of human T-cell leukemia virus type I
Q35575009Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection
Q39042631Muscle MRI findings of HTLV-1-associated myelopathy
Q36687133Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins
Q41236165Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation?
Q42091359Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression
Q45435678Mycosis fungoides in European Russia: no antibodies to human T cell leukemia virus type I structural proteins, but virus-like sequences in blood and saliva.
Q35218631Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB
Q43837693N-Terminal domain of HTLV-I integrase. Complexation and conformational studies of the zinc finger
Q39869820Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax.
Q55243194Necropsy findings in HTLV-I associated myelopathy.
Q39543309Neuro-otologic abnormalities in myelopathy associated with human T-cell lymphotropic virus type 1.
Q37741036Neuroimmunity of HTLV-I Infection
Q38128799Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis
Q64093299Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis
Q43497442Neurologic manifestations related to HTLV-1 viruses
Q35975547Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study
Q39169639Neurological manifestations in HTLV-I-infected blood donors
Q35475478Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls
Q30803056New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones
Q37435359No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran
Q55242153No evidence of HTLV-1 infection in Japanese multiple sclerosis patients in polymerase chain reaction.
Q39435039No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand
Q92381563Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle
Q39308343Novel complications with HTLV-1-associated myelopathy/tropical spastic paraparesis: interstitial cystitis and persistent prostatitis
Q45788568Nucleotide Sequence and Restriction Fragment Length Polymorphism Analysis of the Long Terminal Repeat of Human T Cell Leukemia Virus Type II
Q38898730Nucleotide sequence analysis of human T-cell lymphotropic virus type I pX and LTR regions from patients with sicca syndrome
Q39385699Ocular lesions in HTLV-1 infected patients from Salvador, State of Bahia: the city with the highest prevalence of this infection in Brazil
Q44956108Ocular manifestations of adult T-cell leukemia/lymphoma. A clinicopathologic study
Q33719211On the etiology of tropical spastic paraparesis and human T-cell lymphotropic virus-I-associated myelopathy
Q38958917Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia
Q40332680Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene
Q26741360P-TEFb goes viral
Q38896947P-TEFb goes viral.
Q33960604PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner
Q35854542PCR-in situ hybridization detection of human T-cell lymphotropic virus type 1 (HTLV-1) tax proviral DNA in peripheral blood lymphocytes of patients with HTLV-1-associated neurologic disease
Q41895077PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo
Q38934680Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients
Q37547042Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission
Q33589322Pathogenesis and treatment of HTLV-I associated myelopathy
Q39445928Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.
Q40874333Pathogenesis of virus-induced demyelination.
Q92489483Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease
Q34981289Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
Q36343823Pathways of cell-cell transmission of HTLV-1
Q40357307Pattern-reversal visual evoked potentials in patients with human T-lymphotropic virus type 1 uveitis
Q39321233Patterns of in vitro lymphoproliferative responses among HTLV-1-infected subjects: upregulation by HTLV-1 during HIV-1 co-infection.
Q45728415Performance certification of gelatin particle agglutination assay for anti-HTLV-1 antibody: inconclusive positive results
Q59352347Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil
Q70249315Peripheral T-cell lymphoma
Q34601530Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens
Q39169634Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy
Q40103935Perturbation of Human T-Cell Leukemia Virus Type 1 Particle Morphology by Differential Gag Co-Packaging.
Q35576980Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I
Q36650699Phorbol esters modulate the phosphorylation of human T-cell leukemia virus type I Tax
Q33783321Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells
Q36632768Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission
Q34349249Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background
Q36685919Phylogeography of Human T-lymphotropic Virus Type 1 (HTLV-1) Lineages Endemic to Japan
Q36957291Physical and in silico approaches identify DNA-PK in a Tax DNA-damage response interactome
Q45087228Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy
Q38700350Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line
Q45397641Polymorphism in the promoter region of the mannose-binding lectin gene among human T-cell lymphotropic virus infected subjects.
Q46255945Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects
Q38874995Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy
Q41695126Possible association between adult T-cell leukemia/lymphoma and acute myeloid leukemia
Q39293022Post-mortem diagnosis of human T lymphotrophic virus type-1 (HTLV-1) associated myelopathy by detection of HTLV-1 DNA in the spinal cord of a patient with post-transfusional myelopathy
Q35475269Post-transplantation HTLV-1 myelopathy in three recipients from a single donor
Q43878038Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.
Q39124766Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy
Q39611439Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis).
Q48047487Prevalence and phylogenetic analysis of HTLV-I isolates in Cameroon, including those of the Baka Pygmy
Q39269319Prevalence of HTLV-1 antibodies in hemodialysis patients in Japan
Q55240710Prevalence of HTLV-I-associated uveitis in the Kanto Plain, Japan.
Q47106331Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil
Q43656509Prevalence of antibodies to HTLV-1 in South American Indians (Mapuches) from Chile
Q33838100Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder
Q38894583Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile.
Q38675283Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status
Q39517698Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
Q37125891Primary isolation of human T-cell leukemia-lymphoma virus types I and II: use for confirming infection in seroindeterminate blood donors
Q41749317Production of tumor necrosis factors by human T cell lines infected with HTLV-1 may cause their high susceptibility to human immunodeficiency virus infection
Q55239494Prognosis of HTLV-I-positive renal transplant recipients.
Q41142042Progressive necrotic myelopathy as a paraneoplastic syndrome: report of a case and some pathogenetic considerations
Q35635312Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.
Q36642754Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway.
Q39826162Propensity for HBZ-SP1 isoform of HTLV-I to inhibit c-Jun activity correlates with sequestration of c-Jun into nuclear bodies rather than inhibition of its DNA-binding activity
Q55240314Prophylaxis of experimental HTLV-I infection in cynomolgus monkeys by passive immunization.
Q59354917Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity
Q41927250Prosultiamine for treatment of lower urinary tract dysfunction accompanied by human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis
Q38294744Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB.
Q37210537Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I
Q41115170Protein-glycosaminoglycan interactions: infectiological aspects
Q38906684Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru
Q37466795Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: a 10-year follow-up of children in Jamaica
Q45364790Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes
Q39528047Provirus expansion and deregulation of apoptosis-related genes in the spinal cord of a rat model for human T-lymphocyte virus type I-associated myeloneuropathy
Q45754312Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities
Q35643970Psychiatric Disorders in HTLV-1-Infected Individuals with Bladder Symptoms
Q44853801Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli
Q39219928Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis
Q40985236Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction
Q38968633Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay
Q35891629Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica
Q35752816Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-Myb
Q41630410Rapid, sensitive, specific, and quantitative detection of human T-cell leukemia virus type 1 sequence in peripheral blood mononuclear cells by an improved polymerase chain reaction method with nested primers
Q28564663Rat CRM1 is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells
Q35604172Recombinant human T-cell leukemia virus types 1 and 2 Tax proteins induce high levels of CC-chemokines and downregulate CCR5 in human peripheral blood mononuclear cells
Q35833427Recombination between feline exogenous and endogenous retroviral sequences generates tropism for cerebral endothelial cells.
Q45428250Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1.
Q43904336Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Q44532346Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120.
Q35023802Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells
Q35832730Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome.
Q33956264Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity.
Q42267362Relevance of molecular tests for HTLV-1 infection as confirmatory tests after the first sero-screening
Q40303602Relevance of retrovirus quantification in cerebrospinal fluid for neurologic diagnosis
Q37568028Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator
Q37093004Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model
Q45865682Requirement of N- and C-terminal regions for enzymatic activity of human T-cell leukemia virus type I protease
Q36380309Resistance to fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy
Q35879289Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection
Q33649071Retinal vasculitis in a mother and her son with human T-lymphotropic virus type 1 associated myelopathy
Q39534459Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Q26853678Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research
Q34895177Retroviral proteins that target the major histocompatibility complex class I.
Q36868753Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease
Q69953799Retrovirus-associated adult T-cell leukemia-lymphoma: an epidemiologic study of five cases among Hawaii-born offspring of migrant Japanese
Q28769657Retroviruses and human disease
Q40062672Rex transregulation of human T-cell leukemia virus type II gene expression.
Q34572250Rheumatoid arthritis and tumor necrosis factor alpha
Q37773234Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer
Q47201640Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.
Q92091882Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence
Q55239807Role of HTLV-I infection in the pathogenesis of Sjögren's syndrome and rheumatoid arthritis.
Q38025392Role of Nucleocytoplasmic RNA Transport during the Life Cycle of Retroviruses
Q36699176Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture
Q39255955Role of neuronal interferon-gamma in the development of myelopathy in rats infected with human T-cell leukemia virus type 1.
Q45150040Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
Q34306720Role of viruses in etiology and pathogenesis of multiple sclerosis
Q24310639SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily
Q57061692STLV-1 co-infection is correlated with an increased SFV proviral load in the peripheral blood of SFV/STLV-1 naturally infected non-human primates
Q38859934SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.
Q37430929Safety of blood transfusion: the Japanese experience
Q33769730Screening of blood donations for HTLV-I/II.
Q39318432Search for human T-cell leukemia virus type I (HTLV-I) proviral sequences by polymerase chain reaction in the central nervous system tissue of HTLV-I-associated myelopathy
Q45753713Search for human T-lymphotropic virus type I carriers among northeastern Chinese
Q37106216Search for retrovirus in the chronic fatigue syndrome
Q34273466Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
Q39149912Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient
Q39216604Sequence analysis of human T cell lymphotropic virus type I (HTLV-I) Env genes amplified from central nervous system tissues of patients with HTLV-I-associated myelopathy or leukemia
Q38889863Sequence and phylogenetic analysis of human T cell lymphotropic virus type 1 from Tumaco, Colombia
Q36504681Seroepidemiology of HTLV-I in relation to that of HIV-1 in the Gauteng region, South Africa, using dried blood spots on filter papers
Q45373744Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile
Q30847345Seroprevalence of human T-lymphotropic virus type 1 in Papua New Guinea and Irian Jaya measured using different western blot criteria
Q39332420Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient
Q37381691Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders.
Q37397113Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-Tax antibody
Q54783970Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count.
Q44406750Significance of Human T-Lymphotropic Virus Type I Indeterminant Serological Findings among Healthy Individuals
Q94523255Signs, meanings and practices of people living with human t-cell lymphotropic virus type 1 or tropical spastic myelopathy
Q34280854Simian T-cell lymphotropic Viruses (STLVs) and lymphomas in African nonhuman primates
Q41381866Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines
Q38911642Six Colombian patients with adult T-cell leukemia/lymphoma
Q33777159Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection
Q41197300Sp1 family proteins recognize the U5 repressive element of the long terminal repeat of human T cell leukemia virus type I through binding to the CACCC core motif
Q35743020Specific interaction of HTLV tax protein and a human type IV neuronal intermediate filament protein
Q58700496Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1)
Q55239412Spontaneous cell proliferation is associated with poor sensitivity to glucocorticoids in patients infected with HTLV.
Q49433316Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5.
Q45751051Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase
Q39138338Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon
Q40062240Strong trans activation of the human cytomegalovirus major immediate-early enhancer by p40tax of human T-cell leukemia virus type I via two repetitive tax-responsive sequence elements
Q33617251Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.
Q45412079Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus
Q55015262Subtype analysis of HTLV-1 in patients with HTLV-1 uveitis.
Q51618022Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation.
Q41757038Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I).
Q41195203Survey of anti-human T-cell leukemia virus type I antibody in family members of patients with adult T-cell leukemia
Q40876611Synthesis and CD studies of an 88-residue peptide containing the main receptor binding site of HTLV-I SU-glycoprotein
Q24650854T helper cell activation and human retroviral pathogenesis
Q35611762T-cell control by human T-cell leukemia/lymphoma virus type 1.
Q55242740T-lymphocyte alveolitis in HTLV-I-associated myelopathy.
Q92154419TREX1 531C>T Polymorphism is Associated with High Proviral Load Levels in HTLV-1-Infected Persons
Q39119691Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells
Q39147176Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Q33826936Tax 1-independent induction of vascular endothelial growth factor in adult T-cell leukemia caused by human T-cell leukemia virus type 1.
Q35139310Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter
Q34647848Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription
Q35838179Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy
Q35184274Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation
Q40553944Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells
Q47107838The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis
Q34562309The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I
Q39606189The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation
Q42720021The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease
Q26768630The Role of HBZ in HTLV-1-Induced Oncogenesis
Q34760052The Sonoda-Tajima Cell Collection: a human genetics research resource with emphasis on South American indigenous populations
Q36173231The Tax-Inducible Actin-Bundling Protein Fascin Is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1).
Q24301990The bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) Tax and represses HTLV-1 long terminal repeat-mediated transcription
Q39139939The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy
Q59354934The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (all
Q37686085The contribution of Asian researchers to the field of rheumatology
Q34199889The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients
Q38789112The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines
Q35894677The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.
Q39512097The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis
Q39055611The effect of rolipram on the production of cytokines in HTLV-I infected cell lines and peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy (HAM).
Q37253315The epidemiology of HTLV-I infection
Q36315236The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation
Q39582339The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein.
Q35077555The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome
Q35882436The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins
Q35861241The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface
Q36655687The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase.
Q35874668The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex
Q37673010The motor evoked potential in AIDS and HAM/TSP: state of the evidence
Q36829681The oncoprotein Tax of the human T-cell leukemia virus type 1 activates transcription via interaction with cellular ATF-1/CREB factors in Saccharomyces cerevisiae.
Q40861471The origin and evolution of human T-cell lymphotropic virus types I and II.
Q36687002The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments.
Q33934512The pathogenesis of the neurological complications of HIV-1 infection.
Q41137663The pathology of the chronic lymphoid leukaemias
Q45772835The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea
Q37192205The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
Q39206753The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis
Q42047960The role of the thymus in development of necrotizing arteritis in transgenic rats carrying the env-pX gene of human T-cell leukemia virus type-I.
Q39119670The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases
Q50941409The seroprevalence of HTLV-I in patients with ocular diseases, pregnant women and healthy volunteers in the Kanto district, central Japan.
Q35883025The simian T-lymphotropic/leukemia virus from Pan paniscus belongs to the type 2 family and infects Asian macaques.
Q36063657The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1.
Q42204031The transcription elongation factor ELL2 is specifically upregulated in HTLV-1-infected T-cells and is dependent on the viral oncoprotein Tax.
Q34387588The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties
Q37952807The tug-of-war between dendritic cells and human chronic viruses
Q37541300The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements
Q28184983The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV
Q36813399Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice
Q35848268Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay.
Q54204709Time to eradicate HTLV-1: an open letter to WHO.
Q45788217Transactivation of human T-cell leukemia virus type 1 by herpes simplex virus type 1
Q33676408Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy
Q41655886Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virus
Q36814951Transactivation of the proenkephalin gene promoter by the Tax1 protein of human T-cell lymphotropic virus type I
Q33938049Transcription factor AP-2 activates gene expression of HTLV-I
Q42280405Transcriptional activation of the interleukin-21 gene and its receptor gene by human T-cell leukemia virus type 1 Tax in human T-cells
Q35898564Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein.
Q39095920Transduction of dominant negative ATF-1 suppresses the pX gene expression in joint fibroblastic cells derived from HTLV-I transgenic rats
Q41658470Transformation of CD8+ T-cells producing a strong cytopathic effect on CD4+ T-cells through syncytium formation by HTLV-II.
Q40065035Transgenic thymocytes are refractory to transformation by the human T-cell leukemia virus type I tax gene
Q40623668Transition of adult T-cell leukemia/lymphoma clones during clinical progression.
Q39252619Transmission of human T-cell leukemia virus type I from a patient with HTLV-I associated myelopathy/tropical spastic paraparesis and an asymptomatic carrier to rabbits
Q30797529Transmission of human T-cell lymphotropic virus type 1 tax to rabbits by tax-only-positive human cells
Q46577818Treatment for HTLV-I associated arthropathy: a case study and synovial tissue culture analysis
Q28972318Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy
Q39153035Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin
Q33566077Treatment of patients with polyarthritis and anti-HTLV-I antibodies with interferon-alpha
Q45739072Trends in the seroprevalence of HTLV-1 in Japanese blood donors in Nagasaki Prefecture, 2000-2006.
Q39049948Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM): Treatment with an Anabolic Steroid Danazol
Q69903357Tropical spastic paraparesis
Q39029919Tropical spastic paraparesis and HTLV-I infection: clinical and epidemiological study in Lima, Peru
Q39403720Tropical spastic paraparesis/HTLV-I associated myelopathy. Etiology and clinical spectrum
Q55240599Tropical spastic paraparesis: a necessary redefinition
Q39877808Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.
Q36132707Tumor immunity against adult T-cell leukemia
Q45832827Two major subgroups of human T-cell leukemia virus-1 in Japan
Q33835940Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus)
Q42200235Ultrasonography and magnetic resonance imaging findings of rheumatoid arthritis-like arthritis in a patient with adult T-cell leukemia
Q39178769Ultrastructural pathology of a Chilean case of tropical spastic paraparesis/human T-cell lymphotropic type I-associated myelopathy (TSP/HAM).
Q40086144Up-regulation of hepatitis C virus replication by human T cell leukemia virus type I-encoded Tax protein
Q41074323Up-regulation of iNOS mRNA expression and increased production of NO in human monoblast cell line, U937 transfected by HTLV-I tax gene.
Q39013619Up-regulation of interleukin-12 receptor expression in peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis
Q37099844Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein
Q38934616Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals
Q37268551Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes.
Q39608040Use of transgenic animals to study human retroviruses
Q39506433Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis
Q60919995Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii
Q44032350Vertical transmission of HTLV-1 in HTLV-1 carrier rat.
Q47571734Viral Oncology: Molecular Biology and Pathogenesis
Q35835490Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells.
Q38100771Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1.
Q33768325Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease
Q55242998Viruses detected in HTLV-I-associated myelopathy and adult T-cell leukaemia are identical on DNA blotting.
Q40475828Viruses, virulence and pathogenicity.
Q35107212Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
Q45843250Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM).
Q36540100XBP-1, a novel human T-lymphotropic virus type 1 (HTLV-1) tax binding protein, activates HTLV-1 basal and tax-activated transcription
Q35065987Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial
Q55239247[Combined infection with HTLV-1 and Strongyloides stercoralis].
Q55239509[Dermatologic lesions in patients infected with the human T-cell lymphotropic virus type 1 (HTLV-1)].
Q55239400[Evaluation of the performance of immunological parameters as indicators for clinical progression of chronic HTLV-1 infection].
Q55239276[HTLV-1 associated myelopathy: clinical and epidemiological profile in a 10-year case series study].
Q55240236[HTLV-I-associated myelopathy, tropical spastic paraparesis: report of the first cases in Sergipe, Brazil]
Q55239557[Infective dermatitis and recurrent strongyloidiasis in a child]
Q55239553[Seroprevalence of human T cell lymphotropic virus infection and associated factors of risk in blood donors of Rio Branco city, AC, Brazil (1998-2001)].
Q55239399[Sociodemographic, epidemiological and behavioral profile of women infected with HTLV-1 in Salvador, Bahia, an endemic area for HTLV].
Q55241130[Tropical spastic paraparesis in the tropics and Brazil. A historical analysis]
Q39879902cis-Acting inhibitory elements within the pol-env region of human T-cell leukemia virus type 1 possibly involved in viral persistence
Q40409057p21X mRNA is expressed as a singly spliced pX transcript from defective provirus genomes having a partial deletion of the pol-env region in human T-cell leukemia virus type 1-infected cells
Q36794695trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene
Q36732129trans activation of nerve growth factor in transgenic mice containing the human T-cell lymphotropic virus type I tax gene

Search more.